Panel · Use case · Corporate Development
Executive Committee Rehearsal.
LiveStakeholder RehearsalRehearse an executive committee discussion of a partnership proposal with simulated finance, R&D, commercial and regulatory voices.
Executive Committee Rehearsal is a ready-made use case for Corporate Development. It ships under the Stakeholder Rehearsal template.
For corporate development leads. You get each simulated constituency's position, where they conflict, the objections with proposed responses and what each would need to move. The constituencies are simulated, not consulted. Claims are cited or marked as gaps.
Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.
The decision
How will a finance lead, an R&D head, a commercial head and a regulatory head discuss a proposal to partner a late-stage asset at the executive committee?
Who is simulated
Executives weigh a deal against development risk and the portfolio. A published industry analysis of success rates gives the finance seat its base rate.
| Constituency simulated | What it is asked | What it works from |
|---|---|---|
| Finance lead | Return, risk and capital: whether the terms are justified against the base rate of success.1 | Industry success rates. |
| R&D head | Whether the science and the remaining trials are credible.2 | Trial designs and guidance for the indication. |
| Commercial head | Whether the asset will earn a place in the market. | Market and payer evidence. |
| Regulatory head | Whether the development path and the data support the label.2 | Agency guidance. |
What the rehearsal does
The base rate frames the finance seat. The industry analysis of development success rates gives the share of programs that move from one phase to the next. The finance seat starts from it and asks how the asset differs.1
Each executive has a different fear. Finance fears capital at risk, R&D fears scientific risk, commercial fears a crowded market, regulatory fears the label. The report names each and the response to prepare.
Order of engagement. At Full depth the report suggests who to brief first so that the strongest objection is heard before the meeting.
Recommended length
Standard
Four constituencies are in the room. Standard depth gives each a seat and ends with what a rehearsal cannot tell you, in about four pages.
You can pick another length on the form. The other two stay available.
Assumptions the rehearsal checks
The rehearsal states the assumptions it makes about each constituency, and says what each gap limits. Examples for this meeting:
- The terms on the table are the terms the licensor will accept.
- The development plan is credible on the stated timeline.
- The committee will weigh the asset against the portfolio and not alone.
Standards, guidance and sources
Frame
The decision practice behind the memo itself is on the template page.
What gets flagged
Any financial figure not supplied by the sponsor, any objection from an executive that the company has not voiced, and any success rate not tied to the indication.
What arrives
- The question put, and who was simulated
- The stakeholder map
- Each constituency's position
- Where they conflict
- Objections and responses
- What each would need to move, and the order to engage
- What a rehearsal cannot tell you
What it will not do
The constituencies are simulated by AI specialists and are not the real people. The rehearsal prepares you for objections you can anticipate and does not predict the live room.
It does not value the asset or predict the committee’s decision.
It is not research with real stakeholders. The constituencies are simulated by AI specialists from stated sources, and they are not the real people.
It does not predict what the live room will say. It prepares you for the objections you can anticipate.
It does not script a response to be repeated. The responses are for you to test and to adapt.
References
- [1] BIO, Informa Pharma Intelligence and QLS. Clinical Development Success Rates and Contributing Factors 2011–2020. February 2021. Known from search results and secondary reports; the figures were not read.
- [2] International Council for Harmonisation. Efficacy guidelines, including ICH E8(R1) and E9(R1). Not read.
Links checked 9 October 2026
These are the sources the template drew on. None of their authors or issuers has reviewed it.
About the Panel service
Each panelist answers in their own voice, then the discussion is drawn together. You get the question and who was in the room, every position in full, what they agreed on, where they split, and what follows. Disagreements are written down rather than smoothed into a consensus nobody actually holds, because the split is usually the part you needed.
To edit a saved template, open New → Panel → From template, or the library rail on the service form.